MMJ Recs

APRIL 1, 2024

We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Cannabis Law Report

MARCH 6, 2022

Inesa talks about an Oregon study oncannabinoid compounds helping COVID and immune systems, live plants vs. dead plants, CBDa, CBDa treatment and results. Michael Sassano CEO and Chairman of the Board Somai Pharmaceuticals. Inesa chooses as her song, Be A Light by Thomas Rhett. INTERVIEW 2. Michael Sassano.

Pharmaceutical 52

Pharmaceutical Compliance Compliance Treatment 52

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . Dronabinol is commonly used as a treatment in cancer patients due to the fact that it can decrease gut transit and increase colon compliance.

Digestion 123

Digestion Treatment Conditions Research and Development 123

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges such as regulatory compliance costs and market saturation may affect the profitability of cannabis businesses.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

JUNE 3, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

Cannabis Law Report

JANUARY 23, 2022

Lophos Pharma is a psychedelic research company primarily focused on novel therapeutic treatments derived from Peyote (Lophophora williamsii). Claire gained substantial pharmaceutical experience from her work in the biotechnology industry before transferring to cannabis in 2017. Greenridez 2.0 Acquisitions Corp.

History 52

History Pharmaceutical Compliance Compliance 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Key Responsibilities. Law School.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD. Position Requirements.

Clinical Trials 52

Clinical Trials Research and Development Therapy Compliance 52

MJ Business Attorneys

JUNE 29, 2018

The FDA’s approval of the drug is just one step toward getting Epidiolex on the market and available to doctors to prescribe as a treatment option. Attorney Charles Feldmann has worked extensively with a variety of state agencies focused on enforcement, licensing, federal risk mitigation, and compliance.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

MARCH 1, 2022

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

MMJ Recs

FEBRUARY 3, 2024

Understanding these regulations is crucial for patients, caregivers, and dispensaries alike to ensure compliance with the law. In Philadelphia, patients must be diagnosed with specific medical conditions to be eligible for medical cannabis treatment.

Legislation 52

Legislation Law Marijuana Dispensary 52

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Therapy 52

Therapy Pharmaceutical Clinical Trials Access 52

Cannabis Law Report

OCTOBER 2, 2021

Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

JUNE 6, 2022

As a trusted leader in evidence-based medication advisory resources for pharmacists and other clinicians, TRC Healthcare is filling that knowledge gap by partnering with the University of Colorado Denver Skaggs School of Pharmacy and Pharmaceutical Sciences. About the Skaggs School of Pharmacy and Pharmaceutical Sciences.

Education 52

Education Research and Development Pharmaceutical Programs 52

Cannabis Law Report

SEPTEMBER 29, 2022

The Therapeutic Goods Administration (TGA) issued 73 infringement notices totalling $972,360 between the medicinal cannabis companies MGC Pharmaceuticals Ltd, Cannatrek Ltd and Little Green Pharma Ltd. If you suspect non-compliance in relation to therapeutic goods, you can report illegal or questionable practices online to the TGA.

Epilepsy 52

Epilepsy Conditions Media Medicine 52

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Cannabis Law Report

JUNE 9, 2021

This shift has the potential to unlock previously unavailable resources for the investigation of psychedelic-assisted treatments applied to our most critical mental health challenges. Pharmaceutical or cannabis industry experience a plus. Assist the organization in preparation for commercialization of a pharmaceutical product.

Research and Development 76

Research and Development Compliance Compliance Education 76

The Blunt Truth

APRIL 20, 2021

The term does not include industrial hemp, as defined in state law, that is grown, dealt, or processed in compliance with state or federal law, unless it has been acquired and formulated with cannabis plant extract by a pharmaceutical processor.

Recreational 77

Recreational Legalization Oil Extraction 77

Cannabis Law Report

JUNE 24, 2021

Luxembourg decrimininalised the sale and prescription of medicinal cannabis for the treatment of chronic pain, cancer, neuro-degenerative, and other chronic diseases starting August 2018, with approved products sold out of the country’s hospital pharmacies. Of the numerous delayed orders, the longest was 60 days in 2020, for a THC product.

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

JANUARY 14, 2022

Unapproved medications such as cannabis in Germany can only be approved on the basis of three criteria: (1) When it is for the treatment of a serious (life-threatening or permanently detrimental to the quality of life) medical condition; (2) Where no other therapy is available; and. (3) Canopy sold the company for a maximum of €122.6

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

JULY 28, 2021

InnarisBio), to develop a novel sol-gel intranasal drug delivery technology to improve treatments for mental health disorders. The sol-gel technology is designed to deliver pharmaceutical compounds as a liquid at room temperature which becomes a gel at body temperature. About atai Life Sciences.

Research and Development 98

Research and Development Programs Treatment Media 98

Cannabis Law Report

SEPTEMBER 14, 2022

The cannabis-based treatment, Sativex, will now be available via NHS prescription in Scotland, to treat spasticity in MS patients. Although a limited number of people have been able to access it via the Peer Approved Clinical System (PACS) Tier 2 individual patient treatment request process.

Treatment 52

Treatment Access Patients Medicine 52

Cannabis Law Report

JULY 30, 2019

Following an encouraging initial US launch, GW Pharmaceuticals’s cannabidiol oral solution is also set to achieve European approval later in 2019. The US approval of Zogenix’s Fintepla, a potential competitor for GW’s drug, has been delayed but still lo… The European Pharmaceutical Review reports.

Epilepsy 40

Epilepsy Pharmaceutical Medicine Treatment 40

Cannabis Law Report

DECEMBER 14, 2019

Upon receipt of a Controlled Drug License from the UK Home Office, after last week’s inspection, Farmako Limited will be fully licensed to pursue pharmaceutical/medical cannabis trading within the UK operating theatre. VANCOUVER, British Columbia, Dec.

Pharmaceutical 59

Pharmaceutical Chronic Pain Patients Epilepsy 59

Cannabis Law Report

JUNE 1, 2021

Prior to UroGen, Mr. Barbera held various leadership roles at Dendreon Pharmaceuticals, Allergan, and Medimmune, among others. About Vicineum™ Vicineum, a locally administered fusion protein, is Sesen Bio’s lead product candidate being developed for the treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC).

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66

Cannabis Law Report

JANUARY 24, 2022

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Edwin (Ed) Tucker, M.D., Dr. Tucker joins Goldfinch Bio from Mirum Pharmaceuticals, where he served as Chief Medical Officer.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

JANUARY 16, 2020

Devonian” or the “Corporation”) (TSXv:GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products, announced today the signature of a lease Agreement with Hzb Pharma Canada Inc. Tweet this. About Devonian. Devonian Health Group Inc.

Extraction 64

Extraction Pharmaceutical Research and Development Terpenes 64

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

AUGUST 17, 2021

Technology licensing should be on the radar for pharmaceutical companies offering drugs for respiratory diseases. Medical Imaging Software Improves Diagnostic Accuracy and Supports Doctors in Designing Better Treatment for Patients. Smart Inhalers Enable High Patient Engagement and Improve Treatment Effectiveness. Cognita Labs.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JANUARY 12, 2022

“Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. ” Gb Sciences’ intellectual property portfolio includes five U.S.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

MMJ Recs

JANUARY 6, 2024

Capsules and pills provide a familiar oral ingestion method, akin to traditional pharmaceuticals. Each type of MMJ product caters to different preferences, medical conditions, and lifestyle choices, ensuring that patients have diverse options for incorporating medical marijuana into their treatment plans.

Chronic Pain 52

Chronic Pain Topical Marijuana Indica 52

Cannabis Law Report

SEPTEMBER 3, 2019

We are delighted to start working with this Licensed Producer, and others, who share our vision of providing the highest quality pharmaceutical-grade products. We are dedicated to making our compliance regimen second-to-none in Australia just as it is in Canada,” said Mr. McCutcheon. Australian Leadership Appointments.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

FEBRUARY 15, 2019

Under strict manufacturing and pharmaceutical standards, 400 grammes of Bedrocan cannabis and 400 grammes of Bedica grown by Dutch biopharmaceutical firm, Bedrocan, was imported by IPS Specials following prescriptions issued for chronic pain at a cost of £695 per private patient. .

History 56

History Legalization Chronic Pain Pharmaceutical 56

Cannabis Law Report

JANUARY 19, 2022

“A primary application for psychedelics is to support psychotherapy for treatment of mental health conditions. Psygen is a privately-held licensed dealer and active pharmaceutical ingredient (“ API “) manufacturer based in Calgary, Alberta. About Psygen.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical Conditions 52

Cannabis Law Report

JANUARY 9, 2019

Now the former finance executive is on a mission to stamp out diabetes in some of the world’s worst-hit areas with a revolutionary marijuana treatment engineered by his firm, Phoenix Life Sciences International. It showed us there were ways to have formulas that were more effective for diabetes, and others for the treatment of cancers.”.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

SEPTEMBER 21, 2021

Do you think there should be a distinction between pharmaceutical cannabis companies vs cannabis grown for adult use retail? . Yes, pharmaceutical and adult-use retail cannabis are two completely different markets and user groups. In a perfect world, how would you manage this issue? . What’s your view from Oregon.

Environment 52

Environment Pharmaceutical Retail Clinical Trials 52

Cannabis Law Report

MAY 9, 2022

The bill is labelled “Production, extraction and distribution of final products of pharmaceutical cannabis of the species Cannabis Sativa L, containing over 0.2% Medical marijuana can relieve their diseases and help them respond better to treatments, if this is deemed necessary by the treating physicians.”.

Extraction 52

Extraction Sativa Pharmaceutical Cultivation 52